113 results
Page 4 of 6
F-3ASR
EX-4.6
2bff3i
4 Apr 22
Automatic shelf registration (foreign)
4:08pm
6-K
EX-99.1
hm4p71j tjc3
4 Apr 22
European Commission Approves KIMMTRAK® (tebentafusp) for the treatment of unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
0wuxe bxgo
3 Mar 22
Immunocore Reports Full Year 2021 Financial Results
7:01am
6-K
EX-99.1
g8v1xim9pmpzuulf
26 Jan 22
Immunocore announces FDA approval of KIMMTRAK® (tebentafusp-tebn) for the treatment of unresectable or metastatic uveal melanoma
4:29pm
6-K
EX-99.1
84ba s6njyg
10 Nov 21
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:01am
6-K
EX-99.1
r56q o20z8ra0
24 Aug 21
Current report (foreign)
4:33pm
S-8
EX-99.6
ocsa8k7 ulfgl
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.7
qspbmacx f0ifxvxm
12 Apr 21
Registration of securities for employees
4:02pm
S-8
EX-99.8
85zr346m
12 Apr 21
Registration of securities for employees
4:02pm
20-F
EX-2.2
ijr4t0b127z
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-1.1
up9kmm 7l
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-2.4
vtcu vmotv
25 Mar 21
Annual report (foreign)
7:01am
20-F
30a9u6t12zwidi
25 Mar 21
Annual report (foreign)
7:01am
20-F
EX-4.20
xh4un46c xsr
25 Mar 21
Annual report (foreign)
7:01am
424B4
92ebw97y
8 Feb 21
Prospectus supplement with pricing info
8:36am
F-1/A
t4m ekw0o
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-4.3
x4on10lw1fe9ptd0
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-1/A
EX-1.1
a5mckicz
3 Feb 21
Registration statement (foreign) (amended)
5:22pm
F-6/A
EX-99
wpavxv1euxxrvo2v24t
2 Feb 21
Registration for ADRs (foreign) (amended)
4:32pm